They identified 3 previously unreported CaSR variants in patients with FHH, which upon bioinformatic analysis using 8 different tools had inconsistent findings, resulting in a conclusion that these were “variants of unknown significance,” a scenario that will be common to many geneticists and clinicians. This evidence concerns the gene CASR and familial hypocalciuric hypercalcemia.